Shanghai Pharmaceuticals Holding Co., Ltd (OTCMKTS:SHPMF) Sees Significant Increase in Short Interest

Shanghai Pharmaceuticals Holding Co., Ltd (OTCMKTS:SHPMFGet Free Report) was the target of a significant increase in short interest in November. As of November 30th, there was short interest totalling 3,676,300 shares, an increase of 40.0% from the November 15th total of 2,625,500 shares. Based on an average daily trading volume, of 1,400 shares, the days-to-cover ratio is currently 2,625.9 days.

Shanghai Pharmaceuticals Stock Performance

OTCMKTS:SHPMF remained flat at $1.27 during mid-day trading on Friday. Shanghai Pharmaceuticals has a 12 month low of $0.99 and a 12 month high of $1.95. The stock has a 50 day simple moving average of $1.58 and a 200-day simple moving average of $1.45.

About Shanghai Pharmaceuticals

(Get Free Report)

Shanghai Pharmaceuticals Holding Co, Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer’s, and inflammatory bowel diseases.

See Also

Receive News & Ratings for Shanghai Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shanghai Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.